← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 1995Last known activity
Mar 1, 2017
Timeline
Drugs by trial phase (9 distinct, 23 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Bipolar Disorder
- Cardiovascular Diseases
- Coronary Artery Disease
- Coronary Disease
- Death
- Death, Sudden, Cardiac
- Disease
- Dyslipidemias
- Glomerulonephritis, IGA
- Heart Diseases
- HIV Infections
- Hypercholesterolemia
- Hyperlipoproteinemia Type II
- Immunologic Deficiency Syndromes
- Infarction
- Kidney Diseases
- Kidney Failure, Chronic
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Myocardial Infarction
- Myocardial Ischemia
- Renal Insufficiency
- Sclerosis
Recent trials (25)
- NCT03018041CollaboratorPhase 3Mar 1, 2017
- NCT03158545CollaboratorN/AOct 10, 2016
- NCT02763514CollaboratorN/ASep 1, 2016
- NCT02661698CollaboratorN/AFeb 1, 2016
- NCT02923804Lead sponsorN/AOct 1, 2015
- NCT02364635Lead sponsorPhase 1Feb 1, 2015
- NCT02376621Lead sponsorPhase 1Oct 1, 2014
- NCT02367937Lead sponsorPhase 1Aug 1, 2014
- NCT02376608Lead sponsorPhase 1Aug 1, 2014
- NCT02373176Lead sponsorPhase 1Jul 1, 2014
- NCT01813110CollaboratorN/AMay 1, 2014
- NCT01744067CollaboratorPhase 4Nov 1, 2013
- NCT01972178Study directorPhase 2Nov 1, 2013
- NCT01972178Lead sponsorPhase 2Nov 1, 2013
- NCT01893515Lead sponsorPhase 2Jul 1, 2013
Details
- Founded
- Oslo, NO Jan 1, 1917
- Last known activity
- Mar 1, 2017